Replicel Life Sciences Stock Analysis
REPCF Stock | USD 0 0 950.00% |
RepliCel Life Sciences is undervalued with Real Value of 0.006962 and Hype Value of 0.001998. The main objective of RepliCel Life pink sheet analysis is to determine its intrinsic value, which is an estimate of what RepliCel Life Sciences is worth, separate from its market price. There are two main types of RepliCel Life's stock analysis: fundamental analysis and technical analysis.
The RepliCel Life pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and RepliCel Life's ongoing operational relationships across important fundamental and technical indicators.
RepliCel |
RepliCel Pink Sheet Analysis Notes
About 68.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.09. RepliCel Life Sciences last dividend was issued on the 10th of August 2016. The entity had 1:10 split on the 10th of August 2016. RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada. Replicel Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for RepliCel Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about RepliCel Life Sciences contact Andrew Schutte at 604 248 8730 or learn more at https://www.replicel.com.RepliCel Life Sciences Investment Alerts
RepliCel Life is way too risky over 90 days horizon | |
RepliCel Life has some characteristics of a very speculative penny stock | |
RepliCel Life appears to be risky and price may revert if volatility continues | |
RepliCel Life Sciences has accumulated 34.26 K in total debt. RepliCel Life Sciences has a current ratio of 0.23, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist RepliCel Life until it has trouble settling it off, either with new capital or with free cash flow. So, RepliCel Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RepliCel Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RepliCel to invest in growth at high rates of return. When we think about RepliCel Life's use of debt, we should always consider it together with cash and equity. | |
The entity reported the revenue of 353.74 K. Net Loss for the year was (4.07 M) with profit before overhead, payroll, taxes, and interest of 353.74 K. | |
RepliCel Life Sciences has accumulated about 228 K in cash with (2.51 M) of positive cash flow from operations. | |
Roughly 68.0% of the company outstanding shares are owned by corporate insiders |
RepliCel Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RepliCel Life's market, we take the total number of its shares issued and multiply it by RepliCel Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of December, RepliCel Life holds the Risk Adjusted Performance of 0.12, coefficient of variation of 694.84, and Variance of 18486.43. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of RepliCel Life, as well as the relationship between them. Please check RepliCel Life Sciences standard deviation, as well as the relationship between the treynor ratio and skewness to decide if RepliCel Life Sciences is priced some-what accurately, providing market reflects its current price of 0.0021 per share. As RepliCel Life Sciences appears to be a penny stock we also advise to check out its jensen alpha numbers.RepliCel Life Sciences Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. RepliCel Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for RepliCel Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
RepliCel Life Outstanding Bonds
RepliCel Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. RepliCel Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most RepliCel bonds can be classified according to their maturity, which is the date when RepliCel Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
RepliCel Life Predictive Daily Indicators
RepliCel Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of RepliCel Life pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | 9.2 T | |||
Rate Of Daily Change | 10.5 | |||
Day Median Price | 0.0021 | |||
Day Typical Price | 0.0021 | |||
Price Action Indicator | 0.001 | |||
Period Momentum Indicator | 0.0019 | |||
Relative Strength Index | 13.95 |
RepliCel Life Forecast Models
RepliCel Life's time-series forecasting models are one of many RepliCel Life's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary RepliCel Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About RepliCel Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how RepliCel Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling RepliCel shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as RepliCel Life. By using and applying RepliCel Pink Sheet analysis, traders can create a robust methodology for identifying RepliCel entry and exit points for their positions.
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada. Replicel Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding RepliCel Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
All Next | Launch Module |
Complementary Tools for RepliCel Pink Sheet analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |